|
Market Closed -
Swiss Exchange
16:30:30 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 133.78 CHF | +1.12% |
|
+4.52% | +22.06% |
| 10-30 | HEALTH ROUNDS-Rise in US colon cancer rates not limited to young adults, analysis finds | RE |
| 10-29 | Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge | RE |
| Market Cap | 307B 275B 253B 229B 428B 29,121B 436B 3,013B 1,210B 15,319B 1,151B 1,127B 48,309B | P/E 2026 * |
23.2x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 341B 306B 281B 255B 476B 32,402B 485B 3,353B 1,346B 17,045B 1,281B 1,253B 53,752B | EV / Sales 2026 * |
5.95x | EV / Sales 2027 * | 5.45x |
| Free-Float |
91.66% | Yield 2026 * |
2.69% | Yield 2027 * | 2.83% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
London S.E.
| 0QLR | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
OTC Markets
| NVSEF | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
CBOE
| Real-time | ||
|
Boerse Muenchen
| NOT | Real-time | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
Wiener Boerse
| NOVN | End-of-day quote | |
|
CBOE
| 0QLR | Real-time |
Last Transcript: Novartis AG
| 1 day | +1.12% | ||
| 1 week | +4.52% | ||
| 1 month | +11.52% | ||
| 3 months | +5.67% | ||
| 6 months | +15.43% | ||
| Current year | +22.06% |
| 1 week | 125.38 |  | 135.06 |
| 1 month | 115.94 | | 135.06 |
| Current year | 107.68 | | 135.06 |
| 1 year | 99.15 | | 135.06 |
| 3 years | 81.1 | | 135.06 |
| 5 years | 72.84 | | 135.06 |
| 10 years | 65.09 | | 135.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| +2.21% | +2.29% | -15.78% | -60.69% | 175B | |
| Average | +2.10% | +5.54% | +40.35% | +70.04% | 443.74B | |
| Weighted average by Cap. | +2.01% | +6.43% | +47.89% | +94.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.38B 51.39B 47.27B 42.83B 80.07B 5,449B 81.57B 564B 226B 2,866B 215B 211B 9,039B | 61.5B 55.08B 50.67B 45.91B 85.81B 5,840B 87.42B 604B 243B 3,072B 231B 226B 9,687B |
| Net income | 13.58B 12.16B 11.19B 10.14B 18.95B 1,290B 19.31B 133B 53.57B 678B 50.97B 49.89B 2,139B | 15.99B 14.32B 13.17B 11.94B 22.31B 1,519B 22.73B 157B 63.07B 799B 60.02B 58.74B 2,519B |
| Net Debt | 34.56B 30.95B 28.47B 25.8B 48.22B 3,281B 49.12B 339B 136B 1,726B 130B 127B 5,443B | 28.54B 25.56B 23.51B 21.3B 39.82B 2,710B 40.56B 280B 113B 1,425B 107B 105B 4,495B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CHF 133.78 | +1.12% | 4,480,157 |
| 29/10/26 | CHF 132.30 | +2.38% | 6,118,905 |
| 28/10/26 | CHF 129.22 | +0.34% | 2,941,763 |
| 27/10/26 | CHF 128.78 | +1.02% | 5,166,869 |
| 26/10/26 | CHF 127.48 | -0.41% | 3,433,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
